Clinical Trials on Parainfluenza Infection in United Kingdom

Total 21068 results

Gilead Sciences

Completed

Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV) (Challenge)

Respiratory Syncytial Virus Infections

United Kingdom
St George's Healthcare NHS Trust

Unknown

Genome Sequencing of Multidrug Resistant Tuberculosis (MDR TB) in Sputum (MDRTB01)

Tuberculosis

United Kingdom
University of Oxford

Completed

Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route

Tuberculosis

United Kingdom
Western Health and Social Care Trust
University of Ulster

Recruiting

Advanced Sensor Based Functional ASsessmenTs in Axial Spondyloarthritis (ASFASTAS)

Axial Spondyloarthritis

United Kingdom
University of Sussex

Completed

The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study (PAD-C)

Cellulitis | Cellulitis of Leg | Antibiotic Duration

United Kingdom
University Hospital Plymouth NHS Trust

Terminated

Compression Therapy for Acute Lower Limb Cellulitis

Lower Limb Cellulitis

United Kingdom
Astellas Pharma Europe Ltd.

Completed

Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) (PROFILE)

Inflammatory Bowel Disease (IBD) | Clostridium Difficile Infection (CDI)

Austria, France, Greece, Italy, Poland, Russian Federation, United Kingdom
Savara Inc.

Completed

Pilot Trial of Inhaled Molgramostim in Nontuberculous Mycobacterial (NTM) Infection (OPTIMA)

Mycobacterium Infections, Nontuberculous

Australia, United Kingdom
Pfizer

Completed

Pharmacokinetics and Safety of RV521 Formulations (C19007)

Respiratory Syncytial Virus Infections

United Kingdom
GlaxoSmithKline

Completed

First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects

Tuberculosis

United Kingdom
University of Oxford

Completed

A Phase I Study to Assess the Safety and Immunogenicity of Tuberculosis (TB) Vaccine Candidates FP85A and MVA85A

Tuberculosis

United Kingdom
Barts & The London NHS Trust
NHS Research and Development

Unknown

Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis?

Tuberculosis

United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom (MET52)

Healthy Volunteers (Meningococcal Infection)

United Kingdom
Forest Laboratories

Completed

Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy

Helicobacter Infections

United Kingdom
Imperial College London

Completed

Mechanisms of Interplay Between Allergy and Viruses in Asthma

Rhinovirus Infection in Asthma

United Kingdom
Kirby Institute
Chelsea and Westminster NHS Foundation Trust

Completed

The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)

HIV Infection

Argentina, South Africa, Thailand, United Kingdom
Novartis Vaccines

Completed

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine

Meningococcal Disease

United Kingdom
University of Oxford
Mason Medical Research Trust

Completed

Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines

Pneumococcal Disease

United Kingdom
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants

Meningococcal Disease

United Kingdom
Novartis Vaccines

Completed

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine

Meningococcal Disease

United Kingdom
GlaxoSmithKline

Completed

Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects

Herpes Zoster

Germany, United States, United Kingdom
Smith & Nephew, Inc.

Terminated

A Pilot Study of the WoundWand™ Debridement Device on Infection Prevention (WoundWand)

Lower Leg Wound

France, United Kingdom
Helen Reynolds
Liverpool University Hospitals NHS Foundation Trust

Completed

The Effect of Intermittent Rifampicin on Raltegravir (RIFRAL)

HIV | Tuberculosis

United Kingdom
Dr Lorna Paul
NHS Greater Glasgow and Clyde

Unknown

WEB-Based Physiotherapy for People With Axial Spondyloarthritis

Ankylosing Spondylitis

United Kingdom
University of Oxford

Completed

Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route

Tuberculosis

United Kingdom
Geert Wanten
Geistlich Pharma AG

Completed

Clinical Trial With Catheter Locking TauroSept® (Taurolidine 2%) or Saline Solution 0,9%

Catheter Related Blood Stream Infections

United Kingdom, Israel, Denmark, Germany, Italy, Netherlands
Niso Biomed S.R.L.

Unknown

Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy

Helicobacter Infections

United Kingdom
Loughborough University
University Hospitals, Leicester

Completed

Exercise Therapy in Patients With Axial Spondyloarthritis (ExTASI)

Arthritis | Axial Spondyloarthritis | Inflammatory Disease

United Kingdom
Imperial College London
Biogen; Invicro

Completed

TSPO PET as a Measure of Post-stroke Brain Inflammation: a Natural History Cohort

Inflammatory Response | Stroke, Ischemic | Stroke, Acute

United Kingdom
Royal Surrey County Hospital NHS Foundation Trust

Completed

PeRioperative Omega Three and the Effect on ImmuNity (PROTEIN)

Colorectal Cancer | Sarcopenia | Surgery | Surgery--Complications | Surgical Site Infection | Nutritional Deficiency | Complication, Postoperative | Infected Wound | Phagocytic Dysfunction

United Kingdom
Medical Entomology Centre
PN Lee Statistics and Computing Ltd; Leeds Health Protection Unit; Nelsons

Completed

Neem Lotion With Combing for Lice

Head Lice | Pediculoses

United Kingdom
Imperial College Healthcare NHS Trust
Barts & The London NHS Trust; Royal Free Hospital NHS Foundation Trust; University... and other collaborators

Active, not recruiting

TB PCR in BAL and EBUS-TBNA (TRiBE)

Tuberculosis

United Kingdom
Pulmocide Ltd

Completed

A Study of PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study

Respiratory Syncytial Virus Infections

United Kingdom
University of Oxford
GlaxoSmithKline; Oxford University Hospitals NHS Trust

Completed

Can we Reduce the Number of Vaccine Injections for Children? (MALTA)

Invasive Meningococcal Disease

United Kingdom
Barts & The London NHS Trust
British Lung Foundation

Completed

Trial of Adjunctive Vitamin D in Tuberculosis Treatment

Tuberculosis, Pulmonary

United Kingdom
Imperial College London

Unknown

Analysis of Human Knee Joint Fluid Using Metabonomic, Genomic and Tribology Techniques

Osteoarthritis | Rheumatoid Arthritis | Septic Arthritis

United Kingdom
Imperial College London
CW+ Charity

Completed

Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus) (REMOTE-COVID)

Coronavirus

United Kingdom
Orlando Health, Inc.
Forest Laboratories

Withdrawn

Ceftaroline in the Treatment of Bone and Joint Infections

Osteomyelitis | Joint Infections

United States
St George's, University of London
Public Health England

Recruiting

Propositive (Protecting Positive People From Meningococcal Infection) Follow-up Study

HIV/AIDS | Meningococcal Disease

United Kingdom
University of Oxford

Completed

A Study of Intranasal ChAdOx1 nCOV-19

Coronavirus

United Kingdom
St George's, University of London

Unknown

Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population (ProPositive)

HIV Infections | Hiv | Meningitis, Meningococcal

United Kingdom
Guy's and St Thomas' NHS Foundation Trust

Unknown

Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread

Gram-Negative Bacterial Infections

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust
The Urology Foundation, UK

Unknown

Hyaluronate for the Treatment and Prevention of Recurrent Urinary Tract Infection in Women Suffering Atrophic Vaginitis (HATPIN)

Urinary Tract Infections | Atrophic Vaginitis

United Kingdom
Public Health England
Department of Health, United Kingdom; Institute of Child Health, London, England

Completed

Hepatitis B Vaccination in Infants (Infanrix)

Pneumococcal Disease | Meningococcal Disease | Diphtheria, Tetanus and Pertussis | Haemophilus Influenzae Serotype b Disease | Hepatitis b

United Kingdom
Queen Mary University of London
LAPresearch UK

Unknown

Dynamic Liver Tests in Liver Disease

Hepatitis B | Hepatitis C

United Kingdom
Genocea Biosciences, Inc.

Completed

Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae

Pneumococcal Infections | Pneumonia, Pneumococcal

United Kingdom
London North West Healthcare NHS Trust

Active, not recruiting

Tuberculosis Drug Levels and Continuous Glucose Monitoring in Diabetic Patients

Diabetes Mellitus | Tuberculosis

United Kingdom
Queen Mary University of London

Completed

Vitamin D to Resolve Inflammation After Tuberculosis (ResolveD-TB) (ResolveD-TB)

Recurrent Tuberculosis

United Kingdom
University College, London
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

CMV Glycoprotein B Vaccine in Allograft Recipients

Cytomegalovirus Infections

United Kingdom
Ridgeback Biotherapeutics, LP

Completed

COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers

Coronavirus

United Kingdom

Clinical Trials on Parainfluenza Infection in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations